Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Nivolumab with or without Tadalafil in Treating Patients with Recurrent Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

This randomized pilot early phase I trial studies how well nivolumab with or without tadalafil work in treating patients with head and neck squamous cell carcinoma that has come back and can be removed by surgery.Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Tadalafil may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving nivolumab and tadalafil may work better in treating patients head and neck squamous cell carcinoma.
Not Available
I
Kim, Young Jun
NCT03238365
VICCHN1794

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: